期刊文献+

内脂素在妊娠期糖尿病发病中的作用及其与胰岛素抵抗的关系 被引量:17

Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance
原文传递
导出
摘要 目的 探讨内脂素在妊娠期糖尿病(GDM)发病中的作用及其与胰岛素抵抗的相关性.方法 选择2013年1月至6月于河北省人民医院妇产科就诊的孕24~ 28周的单胎孕妇58例,根据75 g口服葡萄糖耐量试验(OGTT)结果,分为GDM组30例和健康妊娠(NGT)组28例;同期在体检中心健康体检的糖耐量正常的2型糖尿病一级亲属妇女14例作为高危对照组,糖耐量正常的健康未孕育龄妇女27例为正常对照组.采用葡萄糖氧化酶法检测各组妇女空腹血糖(FPG)、餐后1h及2h血糖水平;采用放射免疫法检测各组妇女空腹胰岛素(FIN)水平并计算稳态模型胰岛素抵抗指数(HOMA-IR);检测各组妇女的总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)及低密度脂蛋白(LDL)水平;ELISA法测定血清内脂素水平.结果 (1)GDM组、高危对照组和正常对照组妇女的FPG水平[分别为(5.5±0.7)、(5.1±0.6)、(5.2±0.4)mmol/L]明显高于NGT组[(4.5±0.3)mmol/L],分别比较,差异均有统计学意义(P<0.05).(2)GDM组妇女FIN水平[(14±6)mU/L]、HOMA-IR(4.0±2.0)、餐后1 h[(10.9±1.8) mmol/L]及2 h[(8.6±1.8) mmol/L]血糖水平,明显高于NGT组[分别为(12±4) mU/L、2.0±1.0、(7.4±1.3)及(6.2±0.9)mmol/L],分别比较,差异均有统计学意义(P<0.05).(3)GDM组妇女TC、TG、HDL及LDL水平分别为(5.5±0.9)、(2.8±0.8)、(1.8±0.4)及(3.3±0.8)mmol/L,NGT组妇女分别为(5.9±0.8)、(2.5±0.7)、(1.9±0.4)及(3.4±0.6) mmol/L,两组妇女血脂水平均明显高于高危对照组及正常对照组,分别比较,差异均有统计学意义(P<0.05).(4)GDM组及NGT组妇女血清内脂素水平[分别为(43±10)、(45±12) μg/L]显著高于高危对照组及正常对照组[分别为(29±9)、(36±7) μg/L],分别比较,差异均有统计学意义(P<0.05);但高危对照组妇女血清内脂素水平则明显低于正常对照组,差异有统计学意义(P<0.05);GDM组妇女血清内脂素水平虽略低于NGT组,但差异无统计学意义(P>0.05).(5)NGT组妇女内脂素水平与FPG、HOMA-IR和TC呈负相关(r=-0.38、-0.44、-0.47,P<0.05).GDM组妇女内脂素水平与FPG、HOMA-IR和TC均无相关性(r=-0.16、-0.01、0.33,P>0.05).而正常对照组血清内脂素水平与FPG和餐后2h血糖呈负相关(r=-0.48、-0.42,P<0.05).结论 内脂素可能是参与GDM妇女糖及脂肪代谢的重要脂肪因子,并与GDM发病和胰岛素抵抗相关. Objective To investigate the role of visfatin in the pathogenesis of gestational diabetes mellitus (GDM)and its correlation with insulin resistance.Methods The study recruited 58 pregnant women of 24 to 28 gestational weeks in People' s Hospital of Hebei Province from January to June 2013.Among them,30 were patients with GDM (GDM group),28 had normal oral glucose tolerance test and was referred as healthy pregnancy group (NGT group).Fourteen age-matched female who were first-degree relatives (FDR1)of type 2 diabetes mellitus patients,and 27 healthy nonpregnant women with normal oral glucose tolerance test were referred as high-risk group and normal controls (NC),respectively.The fasting plasma glucose (FPG),1 hour and 2 hours postprandial glucose levels were measured by glucose oxidase method.The fasting insulin (FIN)levels were measured by radioimmunoassay and the homeostatic model assessment-insulin resistance index (HOMA-IR)was calculated.The levels of total cholesterol (TC),triglycerdes (TG),high density lipoprotein cholesterol (HDL)and low density lipoprotein cholesterol (LDL)were determined.The visfatin levels were measured by ELISA.Results (1)The levels of FPG were significantly higher in GDM,FDRI and NC group [(5.5±0.7),(5.1±0.6),(5.2±0.4) mmol/L] than that in NGT group [(4.5 ± 0.3) mmol/L],respectively (P<0.05).(2) The levels of INS [(14 ± 6) mU/L],HO MA-I R (4.0±2.0),1 hour [(10.9± 1.8) mmol/L] and 2 hours [(8.6± 1.8) mmol/L] postprandial glucose levels of GDM group were significantly higher than those in NGT group [(12±4) mU/L,2.0± 1.0,(7.4± 1.3) and (6.2 ±0.9) mmol/L],respectively (P<0.05).(3)The levels of TC,TG,HDL and LDL levels in GDM group were (5.5±0.9),(2.8±0.8),(1.8±0.4)and(3.3±0.8) mmol/L,and were(5.9 ± 0.8),(2.5 ± 0.7),(1.9 ± 0.4) and (3.4 ± 0.6) mmol/L in NGT group.The levels of lipid in the two groups were significantly higher than those in FDR 1 or NC group,respectively (P<0.05).(4) The levels of visfatin in GDM group and NGT group [(43 ± 10),(45 ± 12) μg/L] were significantly higher than that in FDR1 or NC group [(29±9),(36±7) μg/L],respectively (P<0.05),but the visfatin levels in FDR 1 group were significantly lower than that in NC group (P<0.05).The visfatin levels in GDM group were slightly lower than that in NGT group,but the difference was not statistically significant (P>0.05).(5)The visfatin levels in NGT group were negatively correlated to the levels of FPG,HOMA-IR and TC(r=-0.38,-0.44,-0.47,respectively,P<0.05).But the visfatin levels in GDM group were not correlated with the levels of FPG,HOMA-IR,TC (r=-0.16,-0.01,0.33,respectively,P> 0.05).While in NC group,the levels of visfatin were negatively correlated with FPG and 2 hours postprandial glucose (r=-0.48,-0.42,respectively,P<0.05).Conclusion Visfatin may be an important adipokine that involved in the carbohydrate and lipid metabolism in GDM,and is related to the pathogensis of GDM and insulin resistance.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2014年第8期584-587,共4页 Chinese Journal of Obstetrics and Gynecology
基金 2011年河北省科学技术研究与发展计划(11276103D-25)
关键词 糖尿病 妊娠 烟酰胺磷酸核糖基转移酶 胰岛素抗药性 Diabetes, gestational Nicotinamide phosphoribosyltransferase Insulin resistance
  • 相关文献

参考文献27

  • 1American College of Obstetricians and Gynecologists Commitee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes [J]. Obstet Gynecol, 2001,98:525-538.
  • 2杨慧霞,段涛.健康与疾病的发育起源-DOHaD在中国[M].北京:人民卫生出版社,2013: 36 -96.
  • 3Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin a protein secreted by visceral fat that minics the effects of insulin [J]. Science, 2005,307: 426-430.
  • 4Sonoli SS, Shivprasad S, Prasad CV, et al.Visfatin-a review [J]. Eur Rev Med Pharmaeol Sci, 2011,15: 9-14.
  • 5Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals [J]. Curr Opin Gastroenterol, 2007,23:164-170.
  • 6Filippatos TD, Derdemezis CS, Gazi IF, et al. Increased plasma visfatin levels in subjects with the metabolic syndrome[J]. Eur J Clin Invest, 2008,38: 71-72.
  • 7Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis [J]. J Clin Invest, 2004,113:1318-1327.
  • 8Saddi-Rosa P, Oliveira CS, Giuffrida FM, et al. Visfatin, glucose metabolism and vascular disease: a review of evidence[J]. Diabetol Metab Syndr, 2010,2:21.
  • 9International Association of Diabetes and Pregnancy Study Grops Consensus Panel,Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groupsrecommendations on the diagnosis and classification of hyperglycemia in pregnancy [J]. Diabetes Care,2010,33:676-682.
  • 10Szamatowicz J, Kuzmicki M, Telejko B, et al. Serum visfatin concentration is elevated in pregnant women irrespectively of the presence of gestational diabetes [J]. Ginekol Pol,2009, 80: 14-18.

二级参考文献11

  • 1毛红仙,汪大望,郑景晨,胡素银,吴俊琪.血浆抵抗素与2型糖尿病的相关性[J].中华糖尿病杂志(1006-6187),2005,13(4):274-274. 被引量:13
  • 2杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76
  • 3刘蓉,朱剑,王茜,沈备,刘翠萍,徐宽枫,茅晓东,刘超.不同糖耐量人群及糖尿病患者血浆内脂素与血糖及胰岛功能的关系研究[J].中国实用内科杂志,2007,27(16):1278-1281. 被引量:89
  • 4Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc,2001,60:329-339.
  • 5Hug C, Lodish HF. Visfatin: A new adipokine. Science, 2005,307:366-367.
  • 6Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 2005,307:426-430.
  • 7Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab, 2006,91:295-299.
  • 8Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol, 2005,185:R1-8.
  • 9Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 2005,54:2911-2916.
  • 10Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med, 2005,6:45-50.

共引文献87

同被引文献166

  • 1杨小娟,郭燕楠,关云.连续性血液净化在危重病患者中的应用[J].延安大学学报(医学科学版),2009,7(2). 被引量:2
  • 2牛建民,郭晓玲,张温鏖,赖有行,彭武江.妊娠期糖尿病血清脂联素与胰岛素抵抗和分泌的相关性研究[J].中国实用妇科与产科杂志,2004,20(10):615-617. 被引量:9
  • 3何冰,李书琴,王伟,韩萍.妊娠期糖尿病患者妊娠晚期血脂水平变化与新生儿出生体重的关系[J].中华妇产科杂志,2004,39(10):675-677. 被引量:33
  • 4苏薇,杨尚武.妊娠期糖尿病孕妇静脉血、脐静脉血、胎盘瘦素水平的研究[J].中国优生与遗传杂志,2005,13(1):75-76. 被引量:2
  • 5Oncul M,Tuten A,Erman H,et al.Maternal and cord blood apelin,resistin and visfatin levels in gestational diabetes mellitus[J].Minerva Med,2013,104(5):527-535.
  • 6Park S,Kim MY,Baik SH,et al.Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI[J].Eur J Clin Nutr,2013,67(2):196-201.
  • 7JB,PB,FZ,et al.Visfatin is secreted into the breast milk and is correlated with weight changes of the infant after the birth〔J〕.Diabetes Research&Clinical Practice,2012,96(3):355-361.
  • 8Corporation HP.Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome〔J〕.Biomed Research International,2014,3(1):313-326.
  • 9Sheta YS,Elgohary EA,Sharaf S.Visfatin Between Fact and Fiction;A Marker af Obesity or a New Player in the Pathogenesis of Type 2 Diabetes Mellitus〔J〕.Asian Journal of Scientific Research,2012,11(6):949-957.
  • 10Bitsanis D, Ghebremeskel K, Moodley T, et al. Gestational diabetes rnellitus enhances arachidonic and docosahexae- noic acids in placental phospholipids[J]. Lipids, 2006,41 (4) :341-346.

引证文献17

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部